Table 3. Common complications after EPP [adapted from Taioli et al. (24). Meta-analysis of survival after pleurectomy decortication versus extrapleural pneumonectomy in mesothelioma] (including studies with 100 or more EPPs completed).
Publication | No. of patients in study | No. of EPPs completed | Overall morbidity | Complications [n] |
---|---|---|---|---|
Mordant et al., 2016 (6) | 126 | 126 | CTX: 29.7%, IMRT: 35.5% | AF [21] |
Sharkey et al., 2016 (7) | 362 | 133 | 37.15% | AF [29], BPF [9], PE [3], PF [11] |
Stahel et al., 2015 (8) | 151 | 113 | NR | BPF [4], PE [3] |
Bovolato et al., 2014 (9) | 1,365 | 301 | 21.6% | AF [32], ARDS [1], BPF [3], DVT [2], PE [3], PF [3] |
Lauk et al., 2014 (10) | 251 | 251 | major: 30% | AF [67], ARDS [3], BPF [20], PE [9], PF [12] |
Spaggiari et al., 2014 (12) | 518 | 518 | major: 26.3% | AF [18.7%], BPF [14] |
Flores et al., 2008 (25) | 663 | 385 | NR | DVT [3], PE [6] |
Rice, 2007 (18) | 100 | 100 | 73% | ARDS [8], BF [2], DVT [3], PE [1], PF [3] |
Sugarbaker et al., 1999 (20) | 183 | 183 | 50%, major: 24.5%, minor: 41% | AF [68], DVT [4], PE [3], PF [2] |
AF, atrial fibrillation; ARDS, adult respiratory distress syndrome; BPF, bronchopleural fistula; DVT, deep vein thrombosis; PE, pulmonary embolism; PF, patch failure; EPP, extrapleural pneumonectomy; IMRT, intensity-modulated radiotherapy; CTX, chemotherapy; NR, not reported.